Found: 29
Select item for more details and to access through your institution.
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol.
- Published in:
- 2017
- By:
- Publication type:
- journal article
H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell Lymphoma.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2711, doi. 10.3390/cancers16152711
- By:
- Publication type:
- Article
Measles Virus as an Oncolytic Immunotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 544, doi. 10.3390/cancers13030544
- By:
- Publication type:
- Article
CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 11, p. 1949, doi. 10.1038/mt.2014.160
- By:
- Publication type:
- Article
The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics.
- Published in:
- Pathogens, 2024, v. 13, n. 3, p. 184, doi. 10.3390/pathogens13030184
- By:
- Publication type:
- Article
Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells.
- Published in:
- Pathogens, 2023, v. 12, n. 4, p. 607, doi. 10.3390/pathogens12040607
- By:
- Publication type:
- Article
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 422, p. 1, doi. 10.1126/scitranslmed.aao1641
- By:
- Publication type:
- Article
Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference †.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 2, p. 308, doi. 10.3390/v15020308
- By:
- Publication type:
- Article
Measles Vaccines Designed for Enhanced CD8+ T Cell Activation.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 2, p. 242, doi. 10.3390/v12020242
- By:
- Publication type:
- Article
Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 10, p. 914, doi. 10.3390/v11100914
- By:
- Publication type:
- Article
Chemovirotherapy of Malignant Melanoma with a Targeted and Armed Oncolytic Measles Virus.
- Published in:
- Journal of Investigative Dermatology, 2013, v. 133, n. 4, p. 1034, doi. 10.1038/jid.2012.459
- By:
- Publication type:
- Article
The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract - first clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.237016
- By:
- Publication type:
- Article
The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract - first clinical experience: FAPI-PET/CT for lower GI-tract tumors.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.237016
- By:
- Publication type:
- Article
The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract – first clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1113, doi. 10.2967/jnumed.119.237016
- By:
- Publication type:
- Article
The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract – first clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.237016
- By:
- Publication type:
- Article
The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract – first clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.237016
- By:
- Publication type:
- Article
The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract - first clinical experience: FAPI-PET/CT for lower GI-tract tumors.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.237016
- By:
- Publication type:
- Article
The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract – first clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.237016
- By:
- Publication type:
- Article
The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract - first clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.237016
- By:
- Publication type:
- Article
The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract - first clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.237016
- By:
- Publication type:
- Article
The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract – first clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.237016
- By:
- Publication type:
- Article
Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00052
- By:
- Publication type:
- Article
A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 2, p. 1, doi. 10.1038/s41419-023-05624-3
- By:
- Publication type:
- Article
Envelope-chimeric Entry-targeted Measles Virus Escapes Neutralization and Achieves Oncolysis.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 10, p. 1813, doi. 10.1038/mt.2011.92
- By:
- Publication type:
- Article
MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector Tropism.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 6, p. 1097, doi. 10.1038/mt.2011.55
- By:
- Publication type:
- Article
An Immunocompetent Murine Model for Oncolysis with an Armed and Targeted Measles Virus.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 11, p. 1991, doi. 10.1038/sj.mt.6300291
- By:
- Publication type:
- Article
968. Next Generation Measles Virus Vectors for Oncolytic Therapy: Targeted, Armed and Stealth.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S373, doi. 10.1016/j.ymthe.2006.08.1060
- By:
- Publication type:
- Article
309. Oncolytic Efficacy and Enhanced Safety of Measles Virus Activated by Tumor-Secreted Matrix-Metalloproteases.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S118, doi. 10.1016/j.ymthe.2006.08.364
- By:
- Publication type:
- Article
Negative-strand RNA viral vectors: intravenous application of sendai virus vectors for the systemic delivery of therapeutic genes
- Published in:
- Molecular Therapy, 2003, v. 7, n. 2, p. 210, doi. 10.1016/S1525-0016(02)00052-7
- By:
- Publication type:
- Article